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BILIARY SUMMARY
The biliary programme during this World Congress
was both stimulating and varied and covered a whole
range of topics in the form of symposia, update
sessions, debates, videos, free papers and posters.
The main topics discussed included surgical tech-
niques ranging from bile duct resection to robotics,
biliary tumours ranging from choledochol cysts to
carcinoma, calculus disease of the biliary tract,
inflammatory and infectious disorders involving the
bile ducts and motility.
Bile duct injuries were discussed in the forums of
symposia, free papers and posters. With a reported
incidence of 0.4–0.6%, J.-F. Gigot emphasized that the
key to prevention of injury to the bile duct was to
recognize the anatomy of the operating field. Gigot
showed that 87% of bile duct injuries occurred during
dissection of Calot’s triangle and were largely due to
misidentification of the common bile duct (CBD). For
the management of bile duct injuries, D. Carlocke
presented non-operative management using stents and
in particular, using multiple stents. Carlocke demon-
strated that in non-complex bile duct injuries, biliary
stenting succeeded in almost all cases for the control of
bile leaks. For complex bile duct injuries, timing and
local expertise were important factors in determining
the final outcome of these patients (D. J. Gouma, E.
Santiban˜es). Of the oral presentations, A. Sultana
(Liverpool) showed that associated vascular injuries
occurred in one-third of iatrogenic bile duct injuries
with the right hepatic artery most commonly injured.
This occurred in the absence of any vascular anoma-
lies. A retrospective review by M. A. Mercado
(Mexico) of 204 cases of bile duct injuries concluded
that preservation of the biliary confluence resulted in
significantly better outcomes. Of the 10 poster
presentations, F. Ahmad (Leicester) presented an
algorithm for the management of bile leaks following
laparoscopic cholecystectomy. This protocol involved
establishment of drainage, insertion of endoscopic
stent and laparoscopic lavage in cases with peritonitis.
A. M. Smith (Cleveland) posed the question of
whether surveillance following definitive repair of bile
duct injury was warranted. In this prospective surveil-
lance study of 18 patients, 4 patients required stricture
dilation. Of these four, only one presented with
cholangitis, indicating that successful repair of bile
duct injuries can occur in 90% of cases.
The management of gallbladder cancer was pres-
ented in the form of videos, oral presentations and
posters. Of note, was a video presentation involving
central bisegmentectomy with bile duct resection for
advanced gallbladder cancer. This complex dissection
took 722 minutes with an estimated blood loss of 997
ml and good outcomes for the patient after 5 months
(K. Kubota, Japan). Of the oral presentations,—K. M.
Mullerpatan (India) presented preliminary data on
six patients with locally advanced gallbladder cancers
who received neoadjuvant chemotherapy (gemcitabi-
ne+cisplatin). Following radical cholecystectomy, a
450% response was reported. A. Agarwal (India)
reported a prospective cohort of patients with gall-
bladder cancer and biliary obstruction. The presence
of biliary obstruction has generally been viewed as a
sign of inoperability. However, in their cohort of
patients, Agarwal et al. performed radical resection
with curative intent. Of the seven patients reported, the
longest survivor was 39 months, with two patients
surviving 42 years. There were 13 posters on gall-
bladder cancers. Of note, Lee et al. (Korea) retro-
spectively analysed 62 gallbladder cancer specimens
and reported that Cox-2 expression was related to
gallbladder staging, i.e. depth of tumour invasion
and lymph node involvement in a negative fashion.
Freena et al. (Italy) evaluated their 8-year results
for all gallbladder cancers operated with curative
intent. Patients with localized disease had the best
survival.
The interesting and controversial topic of cholan-
giocarcinoma was presented at multiple forums
including a symposium and update sessions, oral
presentations and posters. On preoperative staging,
W. Jarnagin discussed the challenges that have arisen
from advancement in imaging techniques which have
allowed better identification and definition of hilar
structures. As such, preoperative clinical staging is
useful in predicting resectability of hilar cholangio-
carcinoma. The treatment of choice for resectable
disease includes aggressive radical resection, i.e.
surgical resection of extrahepatic bile ducts, liver
resection plus lymphadenectomy and when required
en bloc portal vein resection to achieve negative
histological margins (R0) (P. Neuhaus). Similarly,
resection of hepatic artery may also be required
(M. Miyazaki). On the role of chemoradiation,
R. Adams presented level 3 data indicating anecdotal
benefit of chemoradiation following surgical resection
with margin involvement. The dismal prognosis of
patients with unresectable cholangiocarcinoma was
summarized by T. Todoraki. In his series of patients
with microscopic margin involvement (R1), a survival
benefit was demonstrated from integrated adjuvant
radiotherapy where 5-year survival improved to 40%.
There were 10 oral presentations including 6 from
various units advocating the radical approach. All oral
papers confirmed survival benefit from aggressive
radical resection to achieve negative histological
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margins (R0) with 5-year survival post resection
ranging from 38% to 58%. In addition, factors that
affect survival were identified; these include perineural
invasion, lymph node involvement and histological
differentiation. There were three papers of note on
palliation of the disease: Burger et al. reported effec-
tive palliation with TACE in prolonging survival;
Nanashima et al. reported benefit from their prelim-
inary results using adjuvant photodynamic therapy;
and Andoh et al. reported on improved survival using
postoperative brachytherapy after palliative resection:
5-year survival was 23% comparable to 31% post
curative resection. Of interest, Tonouchi et al. implied
that pancreatic secretory trypsin inhibitor acted as a
marker for early recurrence in intrahepatic cholangio-
carcinoma after surgical resection.
The difficult management of PSC was discussed by
the world’s experts. C. Rosen (Rochester) emphasized
the importance of the detection of cholangiocancers in
patients with PSC as it presents as an insidious disease
with dismal prognosis. Whilst the detection of
cholangiocarcinoma in patients with PSC can pose a
challenge, the clinical triad of jaundice, weight loss and
abdominal discomfort in patients with PSC can be
indicative of these patients having developed cholan-
giocarcinoma. Of the modalities available for the
detection of cancer, they can best be described as
helpful but most lack sensitivity and specificity. On the
endoscopic management of PSC, J. Baillie (Durham)
advocated its role for the treatment of strictures. Large
bile duct strictures (extrahepatic duct andCBD) are on
the whole amenable to endoscopic dilatation and
stenting. Whilst repeated balloon dilatation may be
required, improved survival and symptomatic
improvement in 80% was achievable just by the
maintenance of biliary drainage. However, one must
bear in mind that PSC is a premalignant disease and
hence surgery may be warranted. S. Ahrendt (Roche-
ster) presented the indications for non-transplant
surgery. He advocated the resection of dominant
strictures for the treatment of symptomatic cholangitis
and jaundice and extrahepatic perihilar strictures. The
crucial timing for transplantation was outlined by
P. Baliga (Charleston) but with good outcomes for
those transplanted PSC: overall survival 90% at 1 year,
85% at 5 years, graft survival480 at 1 year, 70–80% at
5 years with recurrence of PSC in 15–25% (increased
in presence of prolonged steroid therapy). There were
two oral presentations on PSC of note. Daryani et al.
reported on the clinical course of UC in patients with/
without PSC. The development of PSC provided a
positive effect on the clinical course of colonic disease.
Jayarajah et al. demonstrated the role of TLR4 in
cholangitis in mice as crucial in response.
On the management of bile duct calculi, three
different approaches were presented. Nathanson et al.
(Brisbane) compared the results of using postoperative
ERCP with laparoscopic choledochotomy for clear-
ance of bile duct calculi in this study of 86 patients who
were deemed unsuitable for transcystic clearance.
There appeared to be no difference between the two
techniques as regards operative time, morbidity and
length of hospital stay. Stromberg et al. (Stockholm)
reported on their retrospective review of 182 patients
who underwent laparoscopic transcystic exploration
of the CBD. The author’s success rate of 74% was
dependent on size, wide CD and no intrahepatic
stones. However, a complication rate of 4.3% was
observed, which included bleeding, cardiopulmonary
problems, pancreatitis and bile leak. The authors
advocated that this single-stage management, which
involved a longer operating time but shorter hospital
stay, avoided the risks of post ERCP pancreatitis. Cox
(NSW, Australia) presented another technique: trans-
cystic stenting at the time of laparoscopic cholecystec-
tomy when CBD calculi are found. Cox advocated
that this two-stage technique facilitates postoperative
ERCP and results in lower occurrence of post ERCP
pancreatitis.
Last but not least, biliary motility was discussed by
several study groups. Graewin et al. (Wisconsin)
demonstrated diminished gallbladder motility in
rotund leptin-resistant obese mice. This significance
can be correlated with the association of human obesity
with gallstones and leptin resistance. Nakeeb et al.
demonstrated that altered glucose metabolism was
associated with impaired GB motility in 180 non-
diabetic volunteers with no gallstones. Hafez et al.
(London) presented evidence that bile flow and
composition are modulated by intravenous glycine in
an in vivo ischaemia-reperfusion injury rabbit model.
Woods et al. (Adelaide) showed that exogenous
adenosine increase sphincter of Oddi motility via
cholinergic motor neurons.
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